OPEN END TURBO BEAR OPTIONSSCHEIN - ELI LILLY & CO | Market Closed - Bid/Ask 02:23:52 2024-06-27 pm EDT | After market 02:45:33 pm | |||
| 1.08 EUR | -23.40% |
|
1.12 | +3.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 1.08 | -23.40% |
| 24-06-26 | 1.41 | +34.29% |
| 24-06-25 | 1.05 | -29.53% |
| 24-06-24 | 1.49 | -43.35% |
| 24-06-21 | 2.63 | +1.94% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 02:23 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD6BW6 |
| ISIN | DE000HD6BW66 |
| Date issued | 2024-06-14 |
| Strike | 910.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.16 € |
|---|---|
| Lowest since issue | 0.66 € |
| Spread | 0.06 € |
| Spread % | 5.66% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- Certificat
